6595 POSTER Phase I Study of Gemcitabine as a Fixed Dose Rate Infusion and S-1 Combination Therapy (FGS) in Gemcitabine-refractory Biliary Tract Cancer (BTC) Patients
Keyword(s):
Phase I
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 5579-5579
2014 ◽
Vol 75
(3)
◽
pp. 457-464
◽